Literature DB >> 36219382

Interaction of Amiodarone with Azoles Against Aspergillus Planktonic Cells and Biofilms in vitro.

Zhimin Duan1, Jianbo Tong2, Nana Zheng1, Rong Zeng3, Yuzhen Liu4, Min Li5,6.   

Abstract

Aspergillus spp. is the most common clinical pathogen of invasive fungal infection with high mortality. Existing treatments for Aspergillus spp. infection are still inefficient and accompanied by drug resistance, so it is still urgent to find new treatment approaches. The antiarrhythmic drug amiodarone (AMD) has demonstrated antifungal activity against a range of fungi. This study evaluated the efficacy of AMD in combination with triazoles for Aspergillus spp. infection. We tested the combined effect of AMD and three triazole drugs, namely, itraconazole (ITR), voriconazole (VRC), and posaconazole (POS), on the planktonic cells and biofilms of 20 strains of Aspergillus spp. via a checkerboard microdilution assay derived from 96-well plate-based method. Our results reveal that the combination of AMD with ITR or POS against Aspergillus biofilms has synergistic fungicidal effects. By contrast, the combination of AMD with VRC exhibits no antagonistic and synergistic effects. In this way, the use of AMD in combination with ITR or POS could be an effective adjunctive treatment for Aspergillus spp. infection.
© 2022. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Amiodarone; Aspergillus; Biofilms; Itraconazole; Posaconazole; Voriconazole

Year:  2022        PMID: 36219382     DOI: 10.1007/s11046-022-00672-3

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   3.785


  15 in total

Review 1.  Systemic fungal infections caused by Aspergillus species: epidemiology, infection process and virulence determinants.

Authors:  Axel A Brakhage
Journal:  Curr Drug Targets       Date:  2005-12       Impact factor: 3.465

2.  Characterization of a novel, broad-based fungicidal activity for the antiarrhythmic drug amiodarone.

Authors:  William E Courchesne
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

3.  Clinical Presentation and Determinants of Mortality of Invasive Pulmonary Aspergillosis in Kidney Transplant Recipients: A Multinational Cohort Study.

Authors:  F López-Medrano; M Fernández-Ruiz; J T Silva; P L Carver; C van Delden; E Merino; M J Pérez-Saez; M Montero; J Coussement; M de Abreu Mazzolin; C Cervera; L Santos; N Sabé; A Scemla; E Cordero; L Cruzado-Vega; P L Martín-Moreno; Ó Len; E Rudas; A P de León; M Arriola; R Lauzurica; M David; C González-Rico; F Henríquez-Palop; J Fortún; M Nucci; O Manuel; J R Paño-Pardo; M Montejo; P Muñoz; B Sánchez-Sobrino; A Mazuecos; J Pascual; J P Horcajada; T Lecompte; A Moreno; J Carratalà; M Blanes; D Hernández; M C Fariñas; A Andrés; J M Aguado
Journal:  Am J Transplant       Date:  2016-05-31       Impact factor: 8.086

4.  New nanotechnological formulation based on amiodarone-loaded lipid core nanocapsules displays anticryptococcal effect.

Authors:  Natália Kronbauer Oliveira; Luiza Abrahão Frank; Eamim Daidrê Squizani; Julia Catarina Vieira Reuwsaat; Bárbara Machado Marques; Heryk Motta; Ane Wichine Acosta Garcia; Uriel Perin Kinskovski; Vanessa Abreu Barcellos; Augusto Schrank; Adriana Raffin Pohlmann; Charley Christian Staats; Sílvia Stanisçuaski Guterres; Marilene Henning Vainstein; Lívia Kmetzsch
Journal:  Eur J Pharm Sci       Date:  2021-03-21       Impact factor: 4.384

5.  Invasive Aspergillosis Due to Aspergillus Section Usti: A Multicenter Retrospective Study.

Authors:  Emmanouil Glampedakis; Sophie Cassaing; Arnaud Fekkar; Eric Dannaoui; Marie-Elisabeth Bougnoux; Stéphane Bretagne; Dionysios Neofytos; Peter W Schreiber; Christophe Hennequin; Florent Morio; Olga Shadrivova; Felix Bongomin; Mario Fernández-Ruiz; Anne Pauline Bellanger; Sevtap Arikan-Akdagli; Veronique Erard; Maria Aigner; Michela Paolucci; Nina Khanna; Eléna Charpentier; Christine Bonnal; Sophie Brun; Frederic Gabriel; Arnaud Riat; Reinhard Zbinden; Patrice Le Pape; Nikolai Klimko; Russel E Lewis; Malcolm Richardson; Ahmet Cagkan İnkaya; Alix T Coste; Pierre-Yves Bochud; Frederic Lamoth
Journal:  Clin Infect Dis       Date:  2021-04-26       Impact factor: 9.079

6.  Antifungal activity of amiodarone is mediated by disruption of calcium homeostasis.

Authors:  Soma Sen Gupta; Van-Khue Ton; Veronica Beaudry; Samuel Rulli; Kyle Cunningham; Rajini Rao
Journal:  J Biol Chem       Date:  2003-05-16       Impact factor: 5.157

7.  In vitro interactions of antifungal agents and tacrolimus against Aspergillus biofilms.

Authors:  Lujuan Gao; Yi Sun
Journal:  Antimicrob Agents Chemother       Date:  2015-08-24       Impact factor: 5.191

8.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.

Authors:  D Neofytos; D Horn; E Anaissie; W Steinbach; A Olyaei; J Fishman; M Pfaller; C Chang; K Webster; K Marr
Journal:  Clin Infect Dis       Date:  2009-02-01       Impact factor: 9.079

9.  Aspergillus fumigatus forms biofilms with reduced antifungal drug susceptibility on bronchial epithelial cells.

Authors:  Marc J Seidler; Stefanie Salvenmoser; Frank-Michael C Müller
Journal:  Antimicrob Agents Chemother       Date:  2008-08-18       Impact factor: 5.191

10.  The Extracellular Matrix of Candida albicans Biofilms Impairs Formation of Neutrophil Extracellular Traps.

Authors:  Chad J Johnson; Jonathan Cabezas-Olcoz; John F Kernien; Steven X Wang; David J Beebe; Anna Huttenlocher; Hamayail Ansari; Jeniel E Nett
Journal:  PLoS Pathog       Date:  2016-09-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.